Predictive Technology Group Inc (PRED)

[High_Profits]

Thermo Fischer Scientific $TMO Major Focus on Precision Medicine / Treatments and Predictive Medicine going forward

Recent Article from August 2019 / as related to PRED
https://tinyurl.com/y4e587cj

Peter Silvester
serves as Senior Vice President and President of Life Sciences Solutions at Thermo Fisher Scientific.

Mr.Silvester provides executive oversight of Thermo Fisher’s biosciences, genetic sciences and clinical next-generation
sequencing businesses as well as life sciences finance, legal, HR, licensing and commercial supply functions. He is a Board Member of
Coriell Life Sciences and Executive Board Member of Biocom.

“Programs which engage all stakeholders academia, industry,
clinicians and patients – to deliver real-world evidence and economic value models to policy makers, regulatory agencies and payers, are what is needed to catalyze the adoption of precision medicine”

According to the U.S. Food & Drug Administration, pharmacogenomics is an
important part of precision medicine. FDA has an interest in determining how a person’s genetic makeup may affect their response to a drug, and how this can assist healthcare providers in “choosing a drug that is more likely to work, avoiding drugs that might have side effects, adjusting the dose of a drug, or determining if closer monitoring is needed.” says Peter Silvester